Please assess the completion status of the following clinical trial:

Trial Title: Hormonal Contraception in Healthy Young Men (P42306)(COMPLETED)(P06057)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male~* Mentally and physically healthy~* BMI between 18 and 32 kg/m\^2~* Two pre-treatment semen samples \> 20 million/ml with normal morphology and motility~Exclusion Criteria:~* History or presence of psychiatric disease, liver disease, renal disease, diabetes, cardiovascular disease, any malignancy, prostatic disease, or genitourinary infection~* PSA \> 2.5 ng/ml~* Use of drugs known to interfere with pharmacokinetics of steroids~* Use of lipid-lowering drugs

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- Arm 1 (Type: ACTIVE_COMPARATOR): etonogestrel with testosterone undecanoate
- Arm 2 (Type: PLACEBO_COMPARATOR): Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).